Impact of carcinoma in situ on the outcome of intravesical Bacillus Calmette-Guérin therapy for non-muscle-invasive bladder cancer: a comparative analysis of large real-world data

Background This study investigated the clinical impact of carcinoma in situ (CIS) in intravesical Bacillus Calmette-Guérin (BCG) therapy for patients with non-muscle-invasive bladder cancer (NMIBC). Methods This study retrospectively evaluated 3035 patients who were diagnosed with NMIBC and treated...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	International journal of clinical oncology 2022-05, Vol.27 (5), p.958-968
Hauptverfasser:	Tomida, Ryotaro, Miyake, Makito, Minato, Ryoei, Sawada, Yuichiro, Matsumura, Masafumi, Iida, Kota, Hori, Shunta, Fukui, Shinji, Ohyama, Chikara, Miyake, Hideaki, Hongo, Fumiya, Taoka, Rikiya, Kobayashi, Takashi, Kojima, Takahiro, Matsui, Yoshiyuki, Nishiyama, Naotaka, Kitamura, Hiroshi, Nishiyama, Hiroyuki, Fujimoto, Kiyohide, Hashine, Katsuyoshi
Format:	Artikel
Sprache:	eng
Schlagworte:	Adjuvants, Immunologic - therapeutic use Administration, Intravesical Bacillus BCG Vaccine - therapeutic use Bladder cancer Cancer Research Carcinoma in Situ - drug therapy Carcinoma in Situ - pathology Comparative analysis Cystectomy Female Humans Invasiveness Male Medicine Medicine & Public Health Multivariate analysis Neoplasm Invasiveness Neoplasm Recurrence, Local - drug therapy Oncology Original Article Patients Retrospective Studies Surgical Oncology Tumors Urethra Urinary Bladder Neoplasms - pathology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!